Trial intelligence / Profile preview

Treating Brain Swelling in Pediatric Cerebral Malaria

NCT03300648Phase 3Completed

Sponsor
Michigan State University
Start
Jan 2018
Primary completion
Dec 2023
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

A Phase 3 trial of hypertonic saline in cerebral malaria (CM), sponsored by Michigan State University. Started Jan 2018; status: completed.

02

Drugs

hypertonic saline
03

Conditions

cerebral malaria (CM)

Beyond the preview

Go deeper on NCT03300648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03300648.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call